HomeTARA • NASDAQ
add
Protara Therapeutics Inc
Previous close
$5.22
Day range
$5.23 - $5.45
Year range
$1.68 - $10.48
Market cap
206.03M USD
Avg Volume
599.57K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.59M | 55.58% |
Net income | -14.96M | -57.26% |
Net profit margin | — | — |
Earnings per share | -0.35 | 22.22% |
EBITDA | -16.49M | -55.87% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 122.22M | 36.43% |
Total assets | 156.93M | 54.39% |
Total liabilities | 12.51M | 30.35% |
Total equity | 144.42M | — |
Shares outstanding | 38.58M | — |
Price to book | 1.40 | — |
Return on assets | -25.48% | — |
Return on capital | -26.66% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -14.96M | -57.26% |
Cash from operations | -12.25M | -59.36% |
Cash from investing | -47.72M | -1,720.48% |
Cash from financing | 8.00K | -99.98% |
Net change in cash | -59.96M | -260.55% |
Free cash flow | -7.38M | -36.60% |
About
Founded
2006
Website
Employees
31
